Phase I/II docetaxel, oxaliplatin, and 5-fluorouracil combination chemotherapy in patients with advanced gastric cancer

被引：0
|
作者：
Kim, Sung Rok
Park, Sung-En
Yuh, Young Jin
Sohn, Byeong Seok
Lee, Hye Ran
Song, Hong-Suk
Lee, Kyung-Hee
机构：
[1] Inje Univ Coll Med, Sanggye Paik Hosp, Dept Internal Med, Seoul, South Korea
[2] Inje Univ Sanggye Paik Hosp, Seoul, South Korea
[3] Inje Univ Sch Med, Ilsan Paik Hosp, Gyeonggi Do, South Korea
[4] Keimyung Univ, Dongsan Med Ctr, Dept Internal Med, Daegu, South Korea
[5] Yeungnam Univ Med Ctr, Daegu, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 03期
关键词：
D O I：
10.1200/jco.2015.33.3_suppl.162
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
162
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase II study of paclitaxel, cisplatin, and 5-fluorouracil combination chemotherapy in patients with advanced gastric cancer
    Hwang, Junyl
    Cho, Sang-Hee
    Shim, Hyun Jeong
    Lee, Se-Ryeon
    Ahn, Jae Sook
    Yang, Duk-Hwan
    Kim, Yeo-Kyeoung
    Lee, Je-Jung
    Kim, Hyeoung-Joon
    Chung, Ik-Joo
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2008, 23 (04) : 586 - 591
  • [2] Phase I/II trial of docetaxel plus oxaliplatin and 5-fluorouracil (D-FOX) in patients with untreated, advanced gastric or gastroesophageal cancer
    Ajani, J. A.
    Phan, A.
    Ho, L.
    Tetzlaff, E. D.
    Baker, J.
    Wei, Q.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [3] Phase I/II study of docetaxel, cisplatin, and 5-fluorouracil combination chemoradiotherapy in patients with advanced esophageal cancer
    Tatsuya Miyazaki
    Makoto Sohda
    Naritaka Tanaka
    Shigemasa Suzuki
    Keisuke Ieta
    Makoto Sakai
    Akihiko Sano
    Takehiko Yokobori
    Takanori Inose
    Masanobu Nakajima
    Minoru Fukuchi
    Hitoshi Ojima
    Hiroyuki Kato
    Hiroyuki Kuwano
    Cancer Chemotherapy and Pharmacology, 2015, 75 : 449 - 455
  • [4] Phase I/II study of docetaxel, cisplatin, and 5-fluorouracil combination chemoradiotherapy in patients with advanced esophageal cancer
    Miyazaki, Tatsuya
    Sohda, Makoto
    Tanaka, Naritaka
    Suzuki, Shigemasa
    Ieta, Keisuke
    Sakai, Makoto
    Sano, Akihiko
    Yokobori, Takehiko
    Inose, Takanori
    Nakajima, Masanobu
    Fukuchi, Minoru
    Ojima, Hitoshi
    Kato, Hiroyuki
    Kuwano, Hiroyuki
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (03) : 449 - 455
  • [5] Phase II study of oxaliplatin in combination with continuous infusion of 5-fluorouracil/leucovorin as first-line chemotherapy in patients with advanced gastric cancer
    Hwang, Wei-Shou
    Chao, Tsu-Yi
    Lin, Shen-Fung
    Chung, Chih-Yuan
    Chiu, Chang-Fang
    Chang, Yi-Fang
    Chen, Po-Min
    Chiou, Tzeon-Jye
    ANTI-CANCER DRUGS, 2008, 19 (03) : 283 - 288
  • [6] Multicenter phase II study of docetaxel plus oxaliplatin combination chemotherapy in patients with advanced gastric cancer
    Kim, J.
    Song, H.
    Do, Y.
    Lee, K.
    Kim, M.
    Ryu, H.
    Bae, S.
    Park, G.
    Baek, J.
    Lee, W.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [7] A phase I/II study of combination chemotherapy with gemcitabine and 5-fluorouracil for advanced pancreatic cancer
    Okusaka, Takuji
    Ishii, Hiroshi
    Funakoshi, Akihiro
    Ueno, Hideki
    Furuse, Junji
    Sumii, Toshihiko
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2006, 36 (09) : 557 - 563
  • [8] A phase I/II trial of docetaxel and oxaliplatin in patients with advanced gastric cancer
    Kim, Kyoung Ha
    Park, Young Suk
    Chang, Myung Hee
    Kim, Hyo Song
    Jun, Hyun Jung
    Uhm, Jieun
    Yi, Seong Yoon
    Lim, Do Hyoung
    Ji, Sang Hoon
    Park, Min Jae
    Lee, Jeeyun
    Park, Se Hoon
    Park, Joon Oh
    Lim, Ho Yeong
    Kang, Won Ki
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (02) : 347 - 353
  • [9] A phase I/II trial of docetaxel and oxaliplatin in patients with advanced gastric cancer
    Kyoung Ha Kim
    Young Suk Park
    Myung Hee Chang
    Hyo Song Kim
    Hyun Jung Jun
    Jieun Uhm
    Seong Yoon Yi
    Do Hyoung Lim
    Sang Hoon Ji
    Min Jae Park
    Jeeyun Lee
    Se Hoon Park
    Joon Oh Park
    Ho Yeong Lim
    Won Ki Kang
    Cancer Chemotherapy and Pharmacology, 2009, 64 : 347 - 353
  • [10] PHASE II STUDY OF OXALIPLATIN COMBINED WITH LEUCOVORIN AND 5-FLUOROURACIL AS FIRST-LINE CHEMOTHERAPY IN PATIENTS WITH ADVANCED GASTRIC CANCER
    Lim, J. Y.
    Cho, J. Y.
    Jeung, H.
    Kim, S. H.
    Lee, J.
    ANNALS OF ONCOLOGY, 2008, 19 : 183 - 184
12345